<1S-<1α,3α,7β,8β(4S^*,6R^*),8aβ>>-8-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol | 116996-45-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: <1S-<1α,3α,7β,8β(4S^*,6R^*),8aβ>>-8-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol
• 英文别名: <1S-<1α,3α,7β,8β(4S*,6R*),8aβ>>-8-<2-<6-<2-<<(1,1-Dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol；[1S-(1α,3α,7β,8β(4S^*,6R^*),8aβ)]-8-{2-[6-(2-{[(1,1-dimethylethyl)diphenylsilyl]oxy}ethyl)-2,2-dimethyl-1,3-dioxan-4-yl]ethyl}-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol；(1S,3R,7S,8S,8aR)-8-[2-[(4R,6S)-6-[2-[tert-butyl(diphenyl)silyl]oxyethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-ol
• CAS: 116996-45-3
• 化学式: C₃₈H₅₄O₄Si
• 分子量: 602.93
• InChiKey: KGGQQZLNYCWSQQ-CCSCLMDYSA-N

物化性质

• 沸点：
  649.2±55.0 °C(Predicted)
• 密度：
  1.08±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.41
• 重原子数：
  43.0
• 可旋转键数：
  9.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  47.92
• 氢给体数：
  1.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  <1S-<1α,3α,7β,8β(4S^*,6R^*),8aβ>>-8-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol 在 正丁基锂 、 碳酸氢钠 、 间氯过氧苯甲酸 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 生成 (2S,3S,7S,8S,8aR)-8-[2-[(4R,6S)-6-[2-[tert-butyl(diphenyl)silyl]oxyethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]-2-hydroxy-3,7-dimethyl-3,7,8,8a-tetrahydro-2H-naphthalen-1-one
  参考文献：
  名称：

  Studies on the Degradation of Mevinolin and Compactin: A Formal Route to Semisynthetic Analogs

  摘要：

  Procedures are described for degrading mevinolin (1a) and compactin (1b) into the enone 2, which is a substance that has been elaborated into 1a, 1b, and 3-ethylcompactin (1c). Consequently, 2 serves as an advanced intermediate for the construction of semisynthetic analogues of the mevinic acids. The degradation is based largely on a series of oxidations (epoxidation of allylic and homoallylic double bonds, alpha-hydroxylation of a ketone unit) and on S(N)2' addition of phenyldimethylsilyl cuprates to a vinyl epoxide system). These reactions are applied in a way that leads to 33 and 50, which are then cleaved with Pb(OAc)(4) or NaIO4, respectively.

  DOI：

  10.1021/jo00110a051
• 作为产物：
  描述：

  洛伐他汀 在 lithium aluminium tetrahydride 、 对甲苯磺酸 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 <1S-<1α,3α,7β,8β(4S^*,6R^*),8aβ>>-8-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol
  参考文献：
  名称：

  Formal preparation of semisynthetic analogues of the cholesterol-lowering agent mevinolin

  摘要：

  降胆固醇剂 mevinolin 1 已降解为烯酮 4，而烯酮 4 此前已合成并转化为 mevinolin1、compactin 2 和 3-ethylconipactin3。

  DOI：

  10.1039/c39930000647

文献信息

• Total synthesis of both (+)-compactin and (+)-mevinolin. A general strategy based on the use of a special titanium reagent for dicarbonyl coupling
  作者：Derrick L. J. Clive、K. S. Keshava Murthy、Andrew G. H. Wee、J. Siva Prasad、Gil V. J. Da Silva、Marek Majewski、Paul C. Anderson、Claire F. Evans、Richard D. Haugen

  DOI：10.1021/ja00164a024

  日期：1990.4

  A strategy is described for stereocontrolled synthesis of hypocholesterolemic compounds, (+)-compactin(+)-mevinolin

  描述了一种用于立体控制合成低胆固醇化合物 (+)-compactin(+)-mevinolin 的策略
• Total synthesis of both (+)-compactin and (+)-mevinolin. A general strategy based on the use of a special TiCl3/C8K mixture for dicarbonyl coupling
  作者：Derrick L. J. Clive、K. S. Keshava. Murthy、Andrew G. H. Wee、J. Siva. Prasad、Gil V. J. Da Silva、Marek. Majewski、Paul C. Anderson、Richard D. Haugen、Louis D. Heerze

  DOI：10.1021/ja00228a067

  日期：1988.9
• CLIVE, DERRICK L. J.;MURTHY, K. S. KESHAVA;WEE, ANDREW G. H.;PRASAD, J. S+, J. AMER. CHEM. SOC., 112,(1990) N, C. 3018-3028
  作者：CLIVE, DERRICK L. J.、MURTHY, K. S. KESHAVA、WEE, ANDREW G. H.、PRASAD, J. S+

  DOI：——

  日期：——